Log in

Cesca Therapeutics SEC Filings & 10K Form (NASDAQ:KOOL)

Today's Range N/A
50-Day Range
$1.72
MA: $3.96
$5.32
52-Week Range N/A
Volume1.58 million shs
Average Volume96,680 shs
Market Capitalization$6.53 million
P/E RatioN/A
Dividend YieldN/A
Beta1.07

SEC Filings

Cesca Therapeutics (NASDAQ:KOOL) SEC Filings

DateFilerForm TypeView
03/27/2020
3:50 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2020
8:15 PM
Cesca Therapeutics (Filer)
Form 424B5
03/24/2020
2:31 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2020
4:22 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
4:26 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
6:56 PM
Boyalife Asset Holding II, Inc. (Reporting)
Boyalife Group, Inc. (Reporting)
Cesca Therapeutics (Issuer)
Xu Xiaochun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
3:58 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
12:57 PM
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Cesca Therapeutics (Subject)
Form SC 13G
01/09/2020
2:05 PM
Donaghy Debra (Reporting)
Cesca Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/06/2020
4:20 PM
Cesca Therapeutics (Filer)
Form 424B5
01/05/2020
11:15 PM
Cesca Therapeutics (Filer)
Form EFFECT
01/03/2020
6:16 PM
Boyalife Ltd (0001667753) (Reporting)
Boyalife Asset Holding II, Inc. (Reporting)
Boyalife Group, Inc. (Reporting)
Li Yishu (Reporting)
Cesca Therapeutics (Issuer)
Xu Xiaochun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
4:29 PM
Cesca Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/27/2019
11:19 AM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
11:18 AM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
4:27 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
3:23 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2019
1:40 PM
Cesca Therapeutics (Filer)
Form NT 10-Q
10/31/2019
1:35 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
9:00 AM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
9:00 AM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
1:34 PM
Cesca Therapeutics (Filer)
Form 8-K/A
09/18/2019
5:42 PM
Cesca Therapeutics (Issuer)
JOSEPH THOMIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
5:40 PM
Cesca Therapeutics (Issuer)
Westgate Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
5:39 PM
Cesca Therapeutics (Issuer)
MEDFORD RUSSELL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2019
4:07 PM
Cesca Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/06/2019
4:26 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
4:27 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
11:47 AM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2019
3:34 PM
Cesca Therapeutics (Filer)
Form SD
Specialized Disclosure Report  
06/26/2019
1:51 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2019
2:02 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
11:15 PM
Cesca Therapeutics (Filer)
Form EFFECT
05/14/2019
3:22 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
3:15 PM
Cesca Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2019
2:34 PM
Cesca Therapeutics (Filer)
Form DEFA14A
04/30/2019
2:42 PM
Cesca Therapeutics (Filer)
Form DEF 14A
04/10/2019
11:49 AM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
1:16 PM
Cesca Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2019
3:22 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
1:20 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2019
12:44 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
9:09 AM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2019
3:29 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
12:51 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2018
7:00 PM
Cauble Jeffery (Reporting)
Cesca Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
6:57 PM
Cesca Therapeutics (Issuer)
Xu Xiaochun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2018
4:01 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2018
11:15 PM
Cesca Therapeutics (Filer)
Form EFFECT
09/19/2018
2:18 PM
Cesca Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/19/2018
2:13 PM
Cesca Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/05/2018
1:48 PM
Cesca Therapeutics (Issuer)
JOSEPH THOMIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2018
4:32 PM
Cesca Therapeutics (Issuer)
JOSEPH THOMIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2018
5:05 AM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
11:28 AM
Cesca Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2018
3:15 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2018
3:16 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2018
6:57 PM
Cesca Therapeutics (Issuer)
Xu James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
3:58 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2018
2:45 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2018
4:26 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2018
11:41 AM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2018
11:48 AM
Cesca Therapeutics (Filer)
Form SD
Specialized Disclosure Report  
05/25/2018
3:11 PM
Cesca Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G
05/22/2018
4:18 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2018
4:16 PM
Cesca Therapeutics (Filer)
Form DEFA14A
05/18/2018
4:21 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2018
2:45 PM
Cesca Therapeutics (Filer)
Form POS EX
05/16/2018
11:15 PM
Cesca Therapeutics (Filer)
Form EFFECT
05/16/2018
4:17 PM
Cesca Therapeutics (Filer)
Form S-1MEF
05/16/2018
5:04 AM
Cesca Therapeutics (Filer)
Form S-1/A
05/14/2018
4:17 PM
Cesca Therapeutics (Filer)
Form S-1/A
05/14/2018
3:09 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
4:15 PM
Cesca Therapeutics (Subject)
Form FWP
05/08/2018
4:09 PM
Cesca Therapeutics (Filer)
Form S-1/A
05/07/2018
3:06 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2018
5:54 PM
Boyalife Asset Holding II, Inc. (Reporting)
Boyalife Group, Inc. (Reporting)
Cesca Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/18/2018
6:51 PM
Cesca Therapeutics (Issuer)
Li Yishu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2018
6:50 PM
Cesca Therapeutics (Issuer)
Xu Xiaochun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2018
4:42 PM
Cesca Therapeutics (Issuer)
Xu James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2018
4:40 PM
Cesca Therapeutics (Issuer)
MEDFORD RUSSELL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2018
4:40 PM
Cesca Therapeutics (Issuer)
JOSEPH THOMIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2018
4:38 PM
Cesca Therapeutics (Issuer)
Westgate Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2018
4:05 PM
Cesca Therapeutics (Filer)
Form PRE 14A
04/17/2018
8:41 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2018
8:39 PM
Cesca Therapeutics (Filer)
Form DEFA14A
04/12/2018
9:24 AM
Cesca Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
04/06/2018
3:34 PM
Cesca Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/30/2018
9:45 AM
Cesca Therapeutics (Filer)
Form CT ORDER
03/28/2018
3:38 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2018
3:31 PM
Cesca Therapeutics (Filer)
Form 424B5
03/22/2018
3:40 PM
Cesca Therapeutics (Filer)
Form 10-KT
03/22/2018
3:22 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2018
12:45 PM
Cesca Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2018
7:03 PM
Cesca Therapeutics (Issuer)
JOSEPH THOMIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
7:03 PM
Cesca Therapeutics (Issuer)
Westgate Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
7:02 PM
Cesca Therapeutics (Issuer)
Xu James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
7:01 PM
Cesca Therapeutics (Issuer)
MEDFORD RUSSELL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
4:21 PM
Cesca Therapeutics (Filer)
Form RW
02/05/2018
6:02 AM
Cesca Therapeutics (Filer)
Form S-1/A
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Featured Article: What is a put option?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel